To evaluate the acceptability of the COVID -19 Rapid Antigen diagnostic tests in the South African setting. This study will evaluate a SAPHRA approved antigen rapid COVID-19 test and a new unregistered but very promising second antigen rapid CPVID-19 test. The overall goal of this project is to establish how the SARS-COV-2 coronavirus is spreading in urban and rural KwaZulu-Natal, in order to guide locally appropriate prevention and clinical care.
Epicentre is conducting the study in partnership with the Centre for the AIDS Programme of Research in South Africa (CAPRISA) and The Foundation for Innovative New Diagnostics (FIND)
You can participate in this study by visiting any of our testing sites within KwaZulu-Natal:
- 12 Inanda Road, Hillcrest
- 3 Kingsmead Way, Stamford Hill, Durban – opposite Kingsmead Cricket Stadium
- Pelham, Pietermaritzburg – Oval Cricket Grounds.
The study will conclude once the study target has been met.
For more information
087 072 5300
Antigen tests, like the name suggests, test for antigens. An COVID-19 Antigen test basically looks for fragments of COVID-19 antigens within a person’s body to see if they’re infected with the virus.
“An antigen is a substance recognized by the body’s immune system, which can [then] respond by generating proteins called antibodies that specifically recognize that antigen,” Albert Shaw, MD, a Yale Medicine infectious disease doctor and professor of medicine at Yale School of Medicine
That basically means, “the point of an antigen test is to detect the presence of a protein—the nucleocapsid protein—which is part of the SARS-CoV-2 virus that is the cause of COVID-19.” [Dr Shaw].